Survivin overexpression is potentially associated with pituitary adenoma invasiveness-Reference-Cited by-同舟云学术

Survivin overexpression is potentially associated with pituitary adenoma invasiveness

Published:2017-11-10 Issue:62 Volume:8 Page:105637-105647
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Kong Xiangyi¹²,Gong Shun³⁴,Su Lijuan⁵,Cheng Xinqi⁶,Li Honglei⁶,You Tingting⁶,Kong Yanguo¹

Affiliation:

1. Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, P.R. China

2. Department of Breast Surgical Oncology, China National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Panjiayuan, Beijing 100021, P.R. China

3. Department of Neurosurgery, Shanghai Institute of Neurosurgery, PLA Institute of Neurosurgery, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai 200003, P.R. China

4. Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, United States of America

5. College of Computer Science and Technology, Zhejiang University, Hangzhou, Zhejiang 310027, P.R. China

6. Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, P.R. China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survivin: A Potential Marker of Resistance to Somatostatin Receptor Ligands;The Journal of Clinical Endocrinology & Metabolism;2022-10-24

2. Comment on: “A Bibliometric Analysis and Visualization of Medical Big Data Research” Sustainability 2018, 10, 166;Sustainability;2018-12-19